In this regard, it remains puzzling how BRCA2 PVs located within the first few hundred nucleotides of the BRCA2 coding sequence, which appear to generate functional “null” alleles, can be attenuated, presumably at least with a contribution of differential splicing, to preferentially cause certain cancers from a broad possible spectrum [16]. This evidence concerns the gene BRCA2 and cancer.